Delivery Order SPE2DB22D3016-SPE2DB25FAUR8
Award Date 4/24/25
Potential Completion Date 5/15/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 ml vials on August 28, 2025, with an ultimate completion date of September 19, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill...
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 mL vials on September 4, 2025, with an ultimate completion date of September 25, 2025. This firm fixed price delivery order represents a non-competitive procurement awarded under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of ONIVYDE 43 mg/10 ml vials valued at $5,345.67 with a firm fixed price structure. This non-set-aside delivery order is scheduled for ultimate completion by July 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of ONIVYDE 43 mg/10 mL vials valued at $10,691.34. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, with performance to be completed at the vendor's Conshohocken, Pennsylvania location. The award represents a non-competitive, non-set-aside delivery order, indicating it was issued under an existing contract vehicle rather than...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of ONIVYDE 43 mg/10 ml vials, with a firm fixed price ceiling value of $10,691.34 and an ultimate completion date of October 8, 2025. This non-set-aside, competitively awarded delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of ONIVYDE 43 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $5,345.67 and is scheduled for completion by September 17, 2025. ONIVYDE is a chemotherapy medication used primarily in cancer treatment regimens. The award represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for ONIVYDE 43 mg/10 ml vials, valued at $10,691.34 under a firm fixed price contract type. The award was made on September 23, 2025, with an ultimate completion date of October 15, 2025, and the work will be performed at the contractor's location in Conshohocken, Pennsylvania. This non-competitive delivery order draws from AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $10,691.34 delivery order to AmerisourceBergen Drug Corp for ONIVYDE 43 mg/10 mL vials on June 5, 2025, with completion targeted for June 27, 2025. ONIVYDE (irinotecan liposome injection) is a chemotherapy agent used in cancer treatment, reflecting the breadth of pharmaceutical products supplied through federal medical procurement channels. This non-competitive delivery order is priced on a firm fixed-price basis and will be performed at the vendor's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $10,691.34 and a performance period ending on May 9, 2025. The contract is a firm-fixed-price delivery order, and it is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
- This federal contract award is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on April 1, 2025, with a ceiling value of $7,127.56 and a completion date of April 22, 2025. The contract is a Delivery Order under a Firm Fixed Price contract type. The award is not associated with a set-aside designation. AmerisourceBergen Drug Corp...